Journal of Pharmacy And Bioallied Sciences
Journal of Pharmacy And Bioallied Sciences Login  | Users Online: 161  Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size 
    Home | About us | Editorial board | Search | Ahead of print | Current Issue | Past Issues | Instructions | Online submission

    Article Cited by others


Appropriateness of drug dose and frequency in patients with renal dysfunction in a tertiary care hospital: A cross-sectional study

Prajapati Arpit, Ganguly Barna

Year : 2013| Volume: 5| Issue : 2 | Page no: 136-140

   This article has been cited by
1 Design, development, and deployment of an indication- and kidney function-based decision support tool to optimize treatment and reduce medication dosing errors
Jamie S Hirsch, Rajdeep Brar, Christopher Forrer, Christine Sung, Richard Roycroft, Pradeep Seelamneni, Hemala Dabir, Ambareen Naseer, Pranisha Gautam-Goyal, Kevin R Bock, Michael I Oppenheim
JAMIA Open. 2021; 4(2)
[Pubmed]  [Google Scholar] [DOI]
2 Incorrect Prescribing for Hemodialysis Patients
Daryl U. Nnani, Timothy Nguyen, Archna Jariwala, Vijay Lapsia
American Journal of Therapeutics. 2020; 27(2): e224
[Pubmed]  [Google Scholar] [DOI]
3 Evaluation of medication dose adjustments in patients with impaired renal function using different online drug information databases
Mesut Sancar, Oznur Altiparmak, Aysenur Altan, Refik Demirtunc, Fikret Vehbi Izzettin, Betul Okuyan
European Journal of Hospital Pharmacy. 2020; : ejhpharm-2
[Pubmed]  [Google Scholar] [DOI]
4 Drug Dosage Adjustment of Chronic Kidney disease Patients at Nephrology Ward in Tertiary Care Hospital of Nepal
Sonu Pakhrin, Sumitra Shrestha, Renu Karki, Nirmal Raj Marasine, Rajendra Lama, Mandip Pokhrel
Europasian Journal of Medical Sciences. 2020; 2(1): 41
[Pubmed]  [Google Scholar] [DOI]
5 Inappropriate prescribing in chronic kidney disease: A systematic review of prevalence, associated clinical outcomes and impact of interventions
Wubshet Hailu Tesfaye,Ronald L. Castelino,Barbara C. Wimmer,Syed Tabish R. Zaidi
International Journal of Clinical Practice. 2017; : e12960
[Pubmed]  [Google Scholar] [DOI]
6 Adherence with renal dosing recommendations in outpatients undergoing haemodialysis
G. J. Kim,N. K. Je,D.-S. Kim,S. Lee
Journal of Clinical Pharmacy and Therapeutics. 2016; 41(1): 26
[Pubmed]  [Google Scholar] [DOI]
7 Pattern and Predictors of Medication Dosing Errors in Chronic Kidney Disease Patients in Pakistan: A Single Center Retrospective Analysis
Ahsan Saleem,Imran Masood,Jeff M Sands
PLOS ONE. 2016; 11(7): e0158677
[Pubmed]  [Google Scholar] [DOI]
8 Influence of kidney disease on drug disposition: An assessment of industry studies submitted to the FDA for new chemical entities 1999-2010
Gary R. Matzke,Thomas C. Dowling,Samantha A. Marks,John E. Murphy
The Journal of Clinical Pharmacology. 2015; : n/a
[Pubmed]  [Google Scholar] [DOI]
9 Use of renal risk drugs in patients with renal impairment
Hilde Holm,Kirsti Bjerke,Lone Holst,Liv Mathiesen
International Journal of Clinical Pharmacy. 2015; 37(6): 1136
[Pubmed]  [Google Scholar] [DOI]
10 Drug Prescribing in Kidney Disease: Canæt We Do Better?
George R. Aronoff,Joel R. Aronoff
American Journal of Kidney Diseases. 2014; 63(3): 382
[Pubmed]  [Google Scholar] [DOI]
11 Ceftriaxone-Induced Acute Encephalopathy in a Peritoneal Dialysis Patient
Sami Safadi,Michael Mao,John J. Dillon
Case Reports in Nephrology. 2014; 2014: 1
[Pubmed]  [Google Scholar] [DOI]
12 Understanding physicians’ behavior toward alerts about nephrotoxic medications in outpatients: a cross-sectional analysis
Insook Cho,Sarah P Slight,Karen C Nanji,Diane L Seger,Nivethietha Maniam,Patricia C Dykes,David W Bates
BMC Nephrology. 2014; 15(1): 200
[Pubmed]  [Google Scholar] [DOI]


Read this article